Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters.
1. |
Name of the issuer |
2. |
State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006). |
|
PRIMARY HEALTH PROPERTIES PLC |
|
(I) (II) and (III) |
3. |
Name of person discharging managerial responsibilities/director |
4. |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person |
|
HARRY HYMAN |
|
CONNECTED TO DIRECTOR HARRY HYMAN |
5. |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial interest 1 |
6. |
Description of shares (including class), debentures or derivatives or financial instruments relating to shares |
|
PURCHASE BY NEXUS GROUP HOLDINGS LIMITED NON BENEFICIAL INTEREST OF DIRECTOR. |
|
ORDINARY SHARES OF 50 PENCE EACH |
7. |
Name of registered shareholders(s) and, if more than one, the number of shares held by each of them |
|
State the nature of the transaction |
|
LLOYDS NOMINEES LIMITED 2,697,660 NEXUS GROUP HOLDINGS LIMITED 40,332 SMITH & WILLIAMSON NOMINEES LIMITED 2,955 CONTRACTS FOR DIFFERENCE over 869,565 ORDINARY SHARES WITH COMMERZBANK AG BERNARD KELLY 128,471 TIM WALKER-ARNOTT 9,082 |
|
ACQUISITION OF 430 NEW ORDINARY SHARES BY NEXUS GROUP HOLDINGS LIMITED ALL NEW ORDINARY SHARES HELD DIRECTLY BY NEXUS GROUP HOLDINGS LIMITED (BEING A TOTAL OF 2,740,947 ORDINARY SHARES INCLUDING THIS PURCHASE) ARE SUBJECT TO THE DEBENTURE AND FIXED CHARGE BY ITS BANK OVER ALL OF ITS ASSETS. |
9. |
Number of shares, debentures or financial instruments relating to shares acquired |
10. |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
|
|
|
|
11. |
Number of shares, debentures or financial instruments relating to shares disposed |
12. |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) |
|
N/A |
|
N/A |
13. |
Price per share or value of transaction |
14. |
Date and place of transaction |
|
282.095 PENCE |
|
2 NOVEMBER 2009, LONDON |
15. |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
|
16. |
Date issuer informed of transaction |
|
56,516 BENEFICIAL 3,748,065 NON-BENEFICIAL 3,804,581 TOTAL 6.20% |
|
2 NOVEMBER 2009 |
If a person discharging managerial responsibilities has been granted options by the issuer
complete the following boxes
17. |
Date of grant |
18. |
Period during which or date on which exercisable |
|
|
|
|
19. |
Total amount paid (if any) for grant of the option |
20. |
Description of shares or debentures involved (class and number) |
|
|
|
|
21. |
Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise |
22. |
Total number of shares or debentures over which options held following notification |
|
|
|
|
23. |
Any additional information |
24. |
Name of contact and telephone number for queries RACHEL BUTLIN, COMPANY SECRETARY, J O HAMBRO CAPITAL MANAGEMENT LIMITED |
|
|
|
|
Name of authorised official of issuer responsible for making notification FOR AND ON BEHALF OF J O HAMBRO CAPITAL MANAGEMENT LIMITED AS COMPANY SECRETARY OF PRIMARY HEALTH PROPERTIES PLC ……………………………………….. RACHEL BUTLIN, COMPANY SECRETARY Date of notification 2 NOVEMBER 2009 |
|
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) |
An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. |
(2) |
An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. |
(3) |
An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. |
(4) |
An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. |